{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:01Z","timestamp":1793916541749,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"crossref","award":["SRG\/2022\/001512"],"award-info":[{"award-number":["SRG\/2022\/001512"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00284-025-04610-6","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:21:13Z","timestamp":1766395273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Framework of Multidrug Resistance in Pseudomonas aeruginosa"],"prefix":"10.1007","volume":"83","author":[{"given":"Mrinalini","family":"Kannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renitta","family":"Jobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish Kumar","family":"Rajasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-3620","authenticated-orcid":false,"given":"Vinothkannan","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"4","key":"4610_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10(4):266\u2013278. https:\/\/doi.org\/10.1038\/nrmicro2761","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"4610_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308946","volume":"19","author":"Z Asmare","year":"2024","unstructured":"Asmare Z, Reta MA, Gashaw Y, Getachew E, Sisay A, Gashaw M, Tamrat E, Kidie AA, Abebe W, Misganaw T, Ashagre A, Dejazmach Z, Kumie G, Nigatie M, Ayana S, Jemal A, Gedfie S, Kassahun W, Kassa MA et al (2024) Antimicrobial resistance profile of Pseudomonas aeruginosa clinical isolates from healthcare-associated infections in Ethiopia: a systematic review and meta-analysis. PLoS ONE 19(8):e0308946. https:\/\/doi.org\/10.1371\/journal.pone.0308946","journal-title":"PLoS ONE"},{"key":"4610_CR3","doi-asserted-by":"publisher","first-page":"e01076","DOI":"10.1128\/AAC.01076-18","volume":"62","author":"K Bush","year":"2018","unstructured":"Bush K (2018) Past and present perspectives on \u03b2-lactamases. Antimicrob Agents Chemother 62:e01076-e1118. https:\/\/doi.org\/10.1128\/AAC.01076-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4610_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/14740338.2021.1928633","volume":"20","author":"P Chandra","year":"2021","unstructured":"Chandra P, Mk U, Ke V, Mukhopadhyay C, U DA, M SR, V R (2021) Antimicrobial resistance and the post antibiotic era: better late than never effort. Expert Opin Drug Saf 20(11):1375\u20131390. https:\/\/doi.org\/10.1080\/14740338.2021.1928633","journal-title":"Expert Opin Drug Saf"},{"key":"4610_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04204-9","volume":"26","author":"J Chastre","year":"2022","unstructured":"Chastre J, Fran\u00e7ois B, Bourgeois M, Komnos A, Ferrer R, Rahav G et al (2022) Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa\u00a0bispecific human monoclonal antibody, in\u00a0P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. Crit Care 26:355. https:\/\/doi.org\/10.1186\/s13054-022-04204-9","journal-title":"Crit Care"},{"issue":"1","key":"4610_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/jgid.jgid_110_18","volume":"11","author":"A Chokshi","year":"2019","unstructured":"Chokshi A, Sifri Z, Cennimo D, Horng H (2019) Global contributors to antibiotic resistance. J Glob Infect Dis 11(1):36\u201342. https:\/\/doi.org\/10.4103\/jgid.jgid_110_18","journal-title":"J Glob Infect Dis"},{"key":"4610_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ (2020) Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00181-19","journal-title":"Clin Microbiol Rev"},{"key":"4610_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0034-1398388","volume":"36","author":"Y Doi","year":"2015","unstructured":"Doi Y, Paterson DL (2015) Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:74\u201384. https:\/\/doi.org\/10.1055\/s-0034-1398388","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"4610_CR9","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1038\/s41598-025-90791-w","volume":"15","author":"R Eid","year":"2025","unstructured":"Eid R, Dabar G, Hanna LR, Saliba G, Riachy M, Choucair J, Saliba R (2025) Comparison of antimicrobial resistance in Pseudomonas aeruginosa from intensive care and non-intensive care units and its impact on treatment decisions. Sci Rep 15(1):11288. https:\/\/doi.org\/10.1038\/s41598-025-90791-w","journal-title":"Sci Rep"},{"key":"4610_CR10","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A, Hendawy AO, De Los R\u00edos-Escalante PR, Aboubakr M, Zakai SA, Nageeb WM (2024) Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol 15:1374466. https:\/\/doi.org\/10.3389\/fmicb.2024.1374466","journal-title":"Front Microbiol"},{"key":"4610_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116405","volume":"461","author":"A Elfadadny","year":"2023","unstructured":"Elfadadny A, Ragab RF, Hamada R, Al Jaouni SK, Fu J, Mousa SA et al (2023) Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: anticancer efficacy and safety. Toxicol Appl Pharmacol 461:116405. https:\/\/doi.org\/10.1016\/j.taap.2023.116405","journal-title":"Toxicol Appl Pharmacol"},{"key":"4610_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jsps.2022.05.008","volume":"30","author":"EK Eltayb","year":"2022","unstructured":"Eltayb EK, Aleanizy FS, Alqahtani FY, Alkahtani HM, Ansari SA, Alsarra I (2022) Preparation and characterization of meta-bromo-thiolactone calcium alginate nanoparticles. Saudi Pharm J 30:946\u2013953. https:\/\/doi.org\/10.1016\/j.jsps.2022.05.008","journal-title":"Saudi Pharm J"},{"key":"4610_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioflm.2023.100129","volume":"5","author":"M Fern\u00e1ndez-Bill\u00f3n","year":"2023","unstructured":"Fern\u00e1ndez-Bill\u00f3n M, Llamb\u00edas-Cabot AE, Jordana-Lluch E, Oliver A, Maci\u00e0 MD (2023) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms. Biofilm 5:100129. https:\/\/doi.org\/10.1016\/j.bioflm.2023.100129","journal-title":"Biofilm"},{"issue":"8","key":"4610_CR14","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1128\/AAC.47.8.2565-2571.2003","volume":"47","author":"M Galimand","year":"2003","unstructured":"Galimand M, Courvalin P, Lambert T (2003) Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 47(8):2565\u20132571. https:\/\/doi.org\/10.1128\/AAC.47.8.2565-2571.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"4610_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijid.2023.04.011","volume":"130","author":"N Geetha","year":"2023","unstructured":"Geetha N, Bhaskaran M, Shamanna V, Marathe S, Ravikumar KL (2023) Diverse genetic background of multidrug resistant Pseudomonas aeruginosa circulating in India. Int J Infect Dis 130:S1\u2013S2. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.011","journal-title":"Int J Infect Dis"},{"issue":"11","key":"4610_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12111621","volume":"12","author":"F Giovagnorio","year":"2023","unstructured":"Giovagnorio F, De Vito A, Madeddu G, Parisi SG, Geremia N (2023) Resistance in Pseudomonas aeruginosa: a narrative review of antibiogram interpretation and emerging treatments. Antibiotics (Basel) 12(11):1621. https:\/\/doi.org\/10.3390\/antibiotics12111621","journal-title":"Antibiotics (Basel)"},{"key":"4610_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/EMPH\/EOAA026","volume":"2020","author":"J Gurney","year":"2020","unstructured":"Gurney J, Pradier L, Griffin JS, Gougat-Barbera C, Chan BK, Turner PE et al (2020) Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa. Evol Med Public Health 2020:148\u2013157. https:\/\/doi.org\/10.1093\/EMPH\/EOAA026","journal-title":"Evol Med Public Health"},{"key":"4610_CR18","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1128\/AAC.48.10.3817-3822.2004","volume":"48","author":"S Hagens","year":"2004","unstructured":"Hagens S, Habel A, Von Ahsen U, Von Gabain A, Bl\u00e4si U (2004) Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob Agents Chemother 48:3817\u20133822. https:\/\/doi.org\/10.1128\/AAC.48.10.3817-3822.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"4610_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmolb.2020.00025","volume":"7","author":"S Hernando-Amado","year":"2020","unstructured":"Hernando-Amado S, Alcalde-Rico M, Gil-Gil T, Valverde JR, Mart\u00ednez JL (2020) Naringenin inhibition of the Pseudomonas aeruginosa quorum sensing response is based on its time-dependent competition with N-(3-Oxo-dodecanoyl)-L-homoserine lactone for LasR binding. Front Mol Biosci 7:25. https:\/\/doi.org\/10.3389\/fmolb.2020.00025","journal-title":"Front Mol Biosci"},{"key":"4610_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.993990","volume":"13","author":"AB Jaglan","year":"2022","unstructured":"Jaglan AB, Anand T, Verma R, Vashisth M, Virmani N, Bera BC et al (2022) Tracking the phage trends: a comprehensive review of applications in therapy and food production. Front Microbiol 13:993990. https:\/\/doi.org\/10.3389\/fmicb.2022.993990","journal-title":"Front Microbiol"},{"key":"4610_CR21","doi-asserted-by":"publisher","first-page":"1191806","DOI":"10.3389\/fcimb.2023.1191806","volume":"13","author":"J Kang","year":"2023","unstructured":"Kang J, Mateu-Borr\u00e1s M, Monroe HL, Sen-Kilic E, Miller SJ, Dublin SR et al (2023) Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice. Front Cell Infect Microbiol 13:1191806. https:\/\/doi.org\/10.3389\/fcimb.2023.1191806","journal-title":"Front Cell Infect Microbiol"},{"key":"4610_CR22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/biomedicines10051169","volume":"10","author":"MT Khayat","year":"2022","unstructured":"Khayat MT, Abbas HA, Ibrahim TS, Khayyat AN, Alharbi M, Darwish KM et al (2022) Anti-quorum sensing activities of gliptins against Pseudomonas aeruginosa and Staphylococcus aureus. Biomedicines 10:1169. https:\/\/doi.org\/10.3390\/biomedicines10051169","journal-title":"Biomedicines"},{"key":"4610_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2022.100025","volume":"4","author":"SF Koya","year":"2022","unstructured":"Koya SF, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC (2022) Consumption of systemic antibiotics in India in 2019. The Lancet Regional Health - Southeast Asia 4:100025. https:\/\/doi.org\/10.1016\/j.lansea.2022.100025","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"4610_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.665759","volume":"11","author":"RF Langendonk","year":"2021","unstructured":"Langendonk RF, Neill DR, Fothergill JL (2021) The building blocks of antimicrobial resistance in Pseudomonas aeruginosa: implications for current resistance-breaking therapies. Front Cell Infect Microbiol 11:665759. https:\/\/doi.org\/10.3389\/fcimb.2021.665759","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4610_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1139\/cjm-2018-0275","volume":"65","author":"NA Lerminiaux","year":"2019","unstructured":"Lerminiaux NA, Cameron ADS (2019) Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol 65(1):34\u201344. https:\/\/doi.org\/10.1139\/cjm-2018-0275","journal-title":"Can J Microbiol"},{"issue":"2","key":"4610_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","volume":"28","author":"X-Z Li","year":"2015","unstructured":"Li X-Z, Pl\u00e9siat P, Nikaido H (2015) The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria. Clin Microbiol Rev 28(2):337\u2013418. https:\/\/doi.org\/10.1128\/CMR.00117-14","journal-title":"Clin Microbiol Rev"},{"key":"4610_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijid.2023.11.023","volume":"139","author":"Y Li","year":"2024","unstructured":"Li Y, Roberts JA, Walker MM, Aslan AT, Harris PNA, Sime FB (2024) The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: a systematic review and meta-analysis. Int J Infect Dis 139:78\u201385. https:\/\/doi.org\/10.1016\/j.ijid.2023.11.023","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4610_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","volume":"27","author":"DM Livermore","year":"2012","unstructured":"Livermore DM (2012) Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 27(2):128\u2013142. https:\/\/doi.org\/10.3904\/kjim.2012.27.2.128","journal-title":"Korean J Intern Med"},{"issue":"8","key":"4610_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jac\/dkt115","volume":"68","author":"C Llanes","year":"2013","unstructured":"Llanes C, Pourcel C, Richardot C, Plesiat P, Fichant G, Cavallo J-D, Merens A, Vu-Thien H, Leclercq R, Romaszko J-P, Poyard C, Marchandin H, Bingen E, Segonds C, Caillon J, Roussel-Delvallez M, Vergnaud G, Hocquet D, Plesiat P, Cavallo J-D (2013) Diversity of -lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosaPseudomonas aeruginosa: a French multicentre study. J Antimicrob Chemother 68(8):1763\u20131771. https:\/\/doi.org\/10.1093\/jac\/dkt115","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4610_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L (2014) Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 5(6):229\u2013241. https:\/\/doi.org\/10.1177\/2042098614554919","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"4610_CR31","first-page":"135","volume":"90","author":"M Lobanovska","year":"2017","unstructured":"Lobanovska M, Pilla G (2017) Penicillin\u2019s discovery and antibiotic resistance: lessons for the future? Yale J Biol Med 90(1):135\u2013145","journal-title":"Yale J Biol Med"},{"issue":"12","key":"4610_CR32","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","volume":"44","author":"N Masuda","year":"2000","unstructured":"Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosaPseudomonas aeruginosa. Antimicrob Agents Chemother 44(12):3322\u20133327. https:\/\/doi.org\/10.1128\/AAC.44.12.3322-3327.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4610_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae001","volume":"6","author":"ND Menon","year":"2024","unstructured":"Menon ND, Somanath P, Jossart J, Vijayakumar G, Shetty K, Baswe M, Chatterjee M, Hari MB, Nair S, Kumar VA, Nair BG, Nizet V, Perry JJP, Kumar GB (2024) Comparative molecular profiling of multidrug-resistant\u00a0Pseudomonas aeruginosa\u00a0identifies novel mutations in regional clinical isolates from South India. JAC Antimicrob Resist 6(1):dlae001. https:\/\/doi.org\/10.1093\/jacamr\/dlae001","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"4610_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.29074\/ascls.24.1.41","volume":"24","author":"NM Moore","year":"2011","unstructured":"Moore NM, Flaws ML (2011) Introduction: Pseudomonas aeruginosa. Am Soc Clin Lab Sci 24(1):41\u201342","journal-title":"Am Soc Clin Lab Sci"},{"key":"4610_CR35","unstructured":"O\u2019Neill J (2016) Review on antimicrobial resistance. Tackling drug-resistant infections globally"},{"key":"4610_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21\u201322","author":"A Oliver","year":"2015","unstructured":"Oliver A, Mulet X, L\u00f3pez-Causap\u00e9 C, Juan C (2015) The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat 21\u201322:41\u201359. https:\/\/doi.org\/10.1016\/j.drup.2015.08.002","journal-title":"Drug Resist Updat"},{"key":"4610_CR37","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1074\/jbc.M116.770552","volume":"292","author":"JE Paczkowski","year":"2017","unstructured":"Paczkowski JE, Mukherjee S, McCready AR, Cong JP, Aquino CJ, Kim H et al (2017) Flavonoids suppress Pseudomonas aeruginosa virulence through allosteric inhibition of quorum-sensing receptors. J Biol Chem 292:4064\u20134076. https:\/\/doi.org\/10.1074\/jbc.M116.770552","journal-title":"J Biol Chem"},{"issue":"1","key":"4610_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177\u2013192. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.11.013","journal-title":"Biotechnol Adv"},{"issue":"9","key":"4610_CR39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrmicro.2016.89","volume":"14","author":"K Papenfort","year":"2016","unstructured":"Papenfort K, Bassler BL (2016) Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol 14(9):576\u2013588. https:\/\/doi.org\/10.1038\/nrmicro.2016.89","journal-title":"Nat Rev Microbiol"},{"key":"4610_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00576-7","volume":"8","author":"A Patel","year":"2017","unstructured":"Patel A, Digiandomenico A, Keller AE, Smith TRF, Park DH, Ramos S et al (2017) An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model. Nat Commun 8:637. https:\/\/doi.org\/10.1038\/s41467-017-00576-7","journal-title":"Nat Commun"},{"key":"4610_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab026","author":"AC Pelegrin","year":"2021","unstructured":"Pelegrin AC, Palmieri M, Mirande C, Oliver A, Moons P, Goossens H, van Belkum A (2021) Pseudomonas aeruginosa\u202f: a clinical and genomics update. FEMS Microbiol Rev. https:\/\/doi.org\/10.1093\/femsre\/fuab026","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"4610_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","volume":"11","author":"JN Pendleton","year":"2013","unstructured":"Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti-Infect Ther 11(3):297\u2013308. https:\/\/doi.org\/10.1586\/eri.13.12","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"4610_CR43","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1128\/jvi.00385-15","volume":"89","author":"DP Pires","year":"2015","unstructured":"Pires DP, Vilas Boas D, Sillankorva S, Azeredo J (2015) Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections. J Virol 89:7449\u20137456. https:\/\/doi.org\/10.1128\/jvi.00385-15","journal-title":"J Virol"},{"key":"4610_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/jac\/dki171","volume":"56","author":"K Poole","year":"2005","unstructured":"Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20\u201351. https:\/\/doi.org\/10.1093\/jac\/dki171","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"4610_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A (2015) Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109(7):309\u2013318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030","journal-title":"Pathog Glob Health"},{"issue":"1","key":"4610_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther 7(1):199. https:\/\/doi.org\/10.1038\/s41392-022-01056-1","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4610_CR47","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","volume":"50","author":"J Quale","year":"2006","unstructured":"Quale J, Bratu S, Gupta J, Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50(5):1633\u20131641","journal-title":"Antimicrob Agents Chemother"},{"key":"4610_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molimm.2019.10.005","volume":"116","author":"M Ranjbar","year":"2019","unstructured":"Ranjbar M, Behrouz B, Norouzi F, Mousavi Gargari SL (2019) Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models. Mol Immunol 116:98\u2013105. https:\/\/doi.org\/10.1016\/j.molimm.2019.10.005","journal-title":"Mol Immunol"},{"issue":"23","key":"4610_CR49","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1016\/j.jmb.2015.08.016","volume":"427","author":"M Rybtke","year":"2015","unstructured":"Rybtke M, Hultqvist LD, Givskov M, Tolker-Nielsen T (2015) Pseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune response. J Mol Biol 427(23):3628\u20133645. https:\/\/doi.org\/10.1016\/j.jmb.2015.08.016","journal-title":"J Mol Biol"},{"key":"4610_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2022.05.010","volume":"148","author":"RF Sanches","year":"2022","unstructured":"Sanches RF, dos Santos Ferraro ACN, Marroni FEC, Venancio EJ (2022) Synergistic activity between beta-lactams and igy antibodies against Pseudomonas aeruginosa in vitro. Mol Immunol 148:1\u20135. https:\/\/doi.org\/10.1016\/j.molimm.2022.05.010","journal-title":"Mol Immunol"},{"key":"4610_CR51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12866-023-02832-x","volume":"23","author":"DRA Sanya","year":"2023","unstructured":"Sanya DRA, On\u00e9sime D, Vizzarro G, Jacquier N (2023) Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections. BMC Microbiol 23:86. https:\/\/doi.org\/10.1186\/s12866-023-02832-x","journal-title":"BMC Microbiol"},{"key":"4610_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","volume":"8","author":"T Sawa","year":"2020","unstructured":"Sawa T, Kooguchi K, Moriyama K (2020) Molecular diversity of extended-spectrum \u03b2-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care 8:13. https:\/\/doi.org\/10.1186\/s40560-020-0429-6","journal-title":"J Intensive Care"},{"key":"4610_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jafr.2024.100973","volume":"15","author":"VP Singh","year":"2024","unstructured":"Singh VP, Jha D, Rehman BU, Dhayal VS, Dhar MS, Sharma N (2024) A mini-review on the burden of antimicrobial resistance and its regulation across one health sectors in India. J Agric Food Res 15:100973. https:\/\/doi.org\/10.1016\/j.jafr.2024.100973","journal-title":"J Agric Food Res"},{"key":"4610_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4161\/bact.20757","volume":"2","author":"WC Summers","year":"2012","unstructured":"Summers WC (2012) The strange history of phage therapy. Bacteriophage 2:130\u2013133. https:\/\/doi.org\/10.4161\/bact.20757","journal-title":"Bacteriophage"},{"issue":"2","key":"4610_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/ijmr.IJMR_331_18","volume":"149","author":"N Taneja","year":"2019","unstructured":"Taneja N, Sharma M (2019) Antimicrobial resistance in the environment: the Indian scenario. Indian J Med Res 149(2):119\u2013128. https:\/\/doi.org\/10.4103\/ijmr.IJMR_331_18","journal-title":"Indian J Med Res"},{"issue":"12","key":"4610_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9120918","volume":"9","author":"K Tiseo","year":"2020","unstructured":"Tiseo K, Huber L, Gilbert M, Robinson TP, Van Boeckel TP (2020) Global trends in antimicrobial use in food animals from 2017 to 2030. Antibiotics (Basel) 9(12):918. https:\/\/doi.org\/10.3390\/antibiotics9120918","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"4610_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG Jr (2019) Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol 17(4):203\u2013218. https:\/\/doi.org\/10.1038\/s41579-018-0147-4","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"4610_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004264","volume":"20","author":"TR Walsh","year":"2023","unstructured":"Walsh TR, Gales AC, Laxminarayan R, Dodd PC (2023) Antimicrobial resistance: addressing a global threat to humanity. PLoS Med 20(7):e1004264. https:\/\/doi.org\/10.1371\/journal.pmed.1004264","journal-title":"PLoS Med"},{"issue":"4","key":"4610_CR59","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00284-011-9979-0","volume":"63","author":"L Wang","year":"2011","unstructured":"Wang L, Zhang C, Gong F, Li H, Xie X, Xia C, Chen J, Song Y, Shen A, Song J (2011) Influence of Pseudomonas aeruginosa pvdQ gene on altering antibiotic susceptibility under swarming conditions. Curr Microbiol 63(4):377\u2013386. https:\/\/doi.org\/10.1007\/s00284-011-9979-0","journal-title":"Curr Microbiol"},{"key":"4610_CR60","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","volume":"72","author":"EM Waters","year":"2017","unstructured":"Waters EM, Neill DR, Kaman B, Sahota JS, Clokie MRJ, Winstanley C et al (2017) Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax 72:666\u2013667. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209265","journal-title":"Thorax"},{"key":"4610_CR61","unstructured":"World Health Organization (2014) Antimicrobial resistance: global report on surveillance. https:\/\/www.who.int\/publications\/i\/item\/9789241564748"},{"key":"4610_CR62","unstructured":"World Health Organization (2019) 2019 WHO AWaRe classification database of antibiotics for evaluation and monitoring of use. WHO, Geneva. Available from:\u00a0https:\/\/www.who.int\/publications\/i\/item\/WHOEMPIAU2019.11"},{"key":"4610_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1139\/cjm-2013-0628","volume":"60","author":"GD Wright","year":"2014","unstructured":"Wright GD (2014) Something old, something new: revisiting natural products in antibiotic drug discovery. Can J Microbiol 60:147\u2013154. https:\/\/doi.org\/10.1139\/cjm-2013-0628","journal-title":"Can J Microbiol"},{"key":"4610_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02066","volume":"9","author":"Y Xie","year":"2018","unstructured":"Xie Y, Tian L, Zhu Y (2018) Antibiotics, resistome and resistance mechanisms. Front Microbiol 9:2066. https:\/\/doi.org\/10.3389\/fmicb.2018.02066","journal-title":"Front Microbiol"},{"issue":"10","key":"4610_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139836","volume":"10","author":"J Yayan","year":"2015","unstructured":"Yayan J, Ghebremedhin B, Rasche K (2015) Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single university hospital center in Germany over a 10-year period. PLoS ONE 10(10):e0139836. https:\/\/doi.org\/10.1371\/journal.pone.0139836","journal-title":"PLoS ONE"},{"issue":"2","key":"4610_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","volume":"32","author":"A Zapun","year":"2008","unstructured":"Zapun A, Contreras-Martel C, Vernet T (2008) Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol Rev 32(2):361\u2013385. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00095.x","journal-title":"FEMS Microbiol Rev"},{"key":"4610_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep15082","volume":"5","author":"HM Zowawi","year":"2015","unstructured":"Zowawi HM, Forde BM, Alfaresi M, Alzarzour Z, Farahat Y, Chong TM, Yin W, Stahl B, Sidjabat HE, Al Jalil E, Al Suwaidi A, Paterson DL (2015) Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae. Sci Rep 5:15082. https:\/\/doi.org\/10.1038\/srep15082","journal-title":"Sci Rep"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04610-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04610-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04610-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:02:32Z","timestamp":1770746552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04610-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4610"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04610-6","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}